Enhancement of C.E.V combination (cisplatin, epirubicin, vindesine) in advanced NSCLC by lonidamine. A phase II randomized trial - Concepedia

Concepedia

Publication | Closed Access

Enhancement of C.E.V combination (cisplatin, epirubicin, vindesine) in advanced NSCLC by lonidamine. A phase II randomized trial

10

Citations

0

References

1994

Year

Giovanni Pietro Ianniello, G. De Cataldis, P. Comella, Ferdinando De Vita, Alfonso Maiorino, L Brancaccio

Advanced NsclcPhase IiMedicinePharmacologyC.e.v CombinationPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyDrug Discovery

No additional data available for this publication yet. Check back later!